News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.
Synthetic Stem Cells Regenerate Heart Tissue in Mice
Diana Kwon | Jun 1, 2017
These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.
Infographic: How to Make an Artificial Stem Cell
Diana Kwon | May 31, 2017
See researchers' recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.
Cell Lines Gain Cancer-Related Mutations
Kerry Grens | Apr 27, 2017
A screen of human embryonic stem cell lines finds several that accumulated changes in the gene
including aberrations commonly seen in cancer.
First Clinic-Ready Stem Cell Repository
Kerry Grens | Apr 6, 2017
The UK Stem Cell Bank offers several lines derived from human embryonic tissue.
Suicide Switch for Transplanted Stem Cells
Abby Olena | Mar 2, 2017
Researchers use an inducible gene to limit tumor growth from human iPSCs transplanted into mice.
Regulators OK Clinical Trials Using Donor Stem Cells
Kerry Grens | Feb 6, 2017
Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.
Q&A: Improving Cardiac Cell Therapy
Kerry Grens | Nov 15, 2016
caught up with cardiac stem cell researcher Mark Sussman to get his thoughts on the American Heart Association’s Scientific Sessions meeting.
Donor Stem Cells Improve Cardiac Function
Kerry Grens | Oct 12, 2016
After a heart attack, monkeys given induced pluripotent stem cell–derived cardiomyocytes show more regeneration in the organ, but with risks.